Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in Pharma

Mankind Pharma Launches Infertility Drug

The company has become the first Indian and second global firm to develop the drug, it claims.

Read More

India Asks States To Halt Online Drug Sales

India is yet to finalise regulations for online drug sales, or e-pharmacies, but the growth of several online sellers such as Medlife, Netmeds, Temasek-backed PharmEasy and Sequoia Capital-backed 1mg has threatened traditional drug-store businesses.

Read More

Bharat Biotech Launches New Rotavirus Vaccine To Tackle Diarrhoea

Rotovac 5D will be affordable and potent even at higher temperatures

Read More

Cipla Arm To Acquire Remaining Stake In Cipla Pharma Lanka

The acquisition of 40 per cent stake is for a cash consideration of four lakh Sri Lankan rupees (about Rs 1.5 lakh) to be paid on closing of the transaction

Read More

Dr Reddy's Q2 Profit Doubles To Rs 1,093 Crore

"I am pleased with our performance across the businesses and strong cash generation during the quarter," said Co-Chairman and Managing Director G V Prasad.

Read More

Strides Pharma Reports Q2 EBITDA At Rs 150 Crore On Revenue Of Rs 718 Crore

EBITDA margins stood at 21 per cent, up by 300 basis point quarter-on-quarter and 1,170 bps year-on-year.

Read More

Glenmark Pharma Gets Tentative Nod From USFDA For Multiple Sclerosis Drug

Glenmark's said its current portfolio consists of 161 products authorised for distribution in the US market and 49 abbreviated new drug applications (ANDAs) pending approval with the USFDA.

Read More

Over View Of API In 2018 Across Globe With Substantive Mention

For the overall industry, Increasing healthcare needs / awareness have resulted in healthcare expenses to grow

Read More

Sun Pharma: Global Is Local

‘We are meticulously nurturing the specialty business and have built a portfolio of about 10 specialty products’

Read More

Sun Pharma Tumbles After Report Of Probe

Markets regulator Securities and Exchange Board of India (SEBI) is likely to reopen an insider trading case against Sun, media sources reported

Read More

Lupin Second-Quarter Profit Dives As U.S. Sales, Higher Expenses Weigh

Lupin's sales in North America, which accounts for nearly a third of total sales, dropped 8.3 percent to 12.49 billion rupees ($169.06 million). Income from operations rose marginally to 38.91 billion rupees

Read More

Supreme Court Allows Sale Of Saridon, 3 Other Drugs

A two judge bench in Supreme Court has allowed the sale of Saridon and three other banned fixed dose combinations (FDCs) amongst 328 drugs banned by the Health Ministry in its Sept 7 notification

Read More

India Bans 328 Combination Drugs In Setback For Pharma Companies

Combination drugs are used to improve patients' compliance, as it is easier to get patients to take one drug rather than several

Read More

HC Suspends Till Oct Centre's Ban on Oxytocin drug production & Sale by Pvt Firms, Next Hearing on Sep 12

HC's interim ban comes on pleas by private firms seeking to set aside the Government's ban on Oxytocin drug production and sale which was to come into effect from tomorrow.

Read More

Fortis Healthcare Quarterly Loss Widens On Impairment Charges

Fortis has become the target of a bidding war by suitors seeking to get a share of a boom in India's private healthcare market

Read More